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Anxiety and depression among outpatients
with type 2 diabetes: A multi-centre study
of prevalence and associated factors
Ali Khan Khuwaja1*, Saima Lalani2, Raheem Dhanani3,4, Iqbal Syed Azam5, Ghazala Rafique5, Franklin White6,7
Abstract
Background: Anxiety and depression contribute to poor disease outcomes among individuals with diabetes. This
study aimed to assess the prevalence of anxiety and depression and to identify their associated factors including
metabolic components among people with type 2 diabetes.
Methods: We conducted a cross-sectional, multi-center study in four out-patient clinics in Karachi, Pakistan. In all,
889 adults with type-2 diabetes were included in this study. Anxiety and depression were measured by using the
Hospital Anxiety and Depression Scale (HADS). Multivariable analysis using multiple logistic regression was carried
out to evaluate the combined effect of various factors associated with anxiety and depression, while adjusting for
confounding variables.
Results: Overall, 57.9% (95% CI = 54.7%, 61.2%) and 43.5% (95% CI = 40.3%, 46.8%) study participants had anxiety
and depression respectively. Factors found to be independently associated with anxiety were physical inactivity,
having hypertension and ischemic heart disease. For depression, being female, of older age, having hypertension
and ischemic heart disease were significantly associated. Metabolic components found to be independently
associated with both anxiety and depression were systolic blood pressure, fasting blood glucose and fasting blood
triglycerides. Body mass index was independently associated with depression but not with anxiety.
Conclusion: This study identified that a large proportion of adults with diabetes had anxiety and/or depression,
and identified factors associated with these entities. These results alert clinicians to identify and treat anxiety and
depression as common components of diabetes care. Additional studies are needed to establish the directional
nature of this relationship and to test interventions.
Background
The global prevalence of diabetes is continuously rising.
It is estimated that almost 285 million people are cur-
rently suffering from diabetes worldwide and the num-
ber is expected to rise to 438 million by the year 2030;
more than 70% of these people reside in developing
countries [1]. Similarly, anxiety and depression affect all
populations worldwide, but more than two-thirds of the
affected people live in developing countries [2]. Both
diabetes and anxiety/depression are associated with pre-
mature morbidity and mortality, and when these condi-
tions co-exist, the risk of developing co-morbidities,
complications, patient suffering and associated cost,
escalates [3,4]. A recent systematic literature review [5]
endorsed that, among people with type 2 diabetes,
depressive symptoms markedly impaired Health Related
Quality of Life (HRQoL) as well.
People with diabetes are almost twice as likely to suf-
fer from anxiety and depression as the general popula-
tion [6,7] but this often remains unrecognized and
thus untreated [8]. The presence of undiagnosed anxi-
ety and depression amongst people with diabetes is
cause for concern as it prevents initiation of treatment
for these concomitant conditions and allows frustration
to build up in patients, thereby contributing to poor
clinical outcomes. Moreover, depression and chronic
psychological stress is known to activate the hypothala-
mic-pitutary-adrenal axis, stimulate the sympathetic
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nervous system, increase inflammatory and platelet
aggregation responses and decrease insulin sensitivity
[9,10], thereby contributing to poor glycaemic control
and increasing the risk of complications. Depressed and
anxious individuals are also less likely to comply with
diabetes self-care recommendations and more likely to
follow sedentary lifestyles, remain physically inactive,
indulge in smoking and high fat diet [11,12], eventually
leading to poor diabetes control and clinical outcomes.
However, it is evident that active case finding and man-
agement of anxiety and depression can assist in alleviat-
ing patient suffering, and contribute to improved
metabolic control and clinical outcomes, while reducing
the costs of patient management [13,14].
Various studies to assess anxiety and depression and
their associated factors among diabetic patients have
been reported from developed countries [15-17]. A
cross-sectional study in the United Kingdom found that
almost one-third of people with diabetes suffer from
anxiety and one-fourth patients suffer from depression
[15]. This study also found diabetes complications and
uncontrolled glycaemic levels as independent factors for
both anxiety and depression [15]. Comparable results
are also documented from other developed countries
[7,16,17].
Similarly, it is important for developing countries to
estimate the prevalence of anxiety and depression and
their associated factors amongst people with diabetes,
thereby to initiate early treatment so as to improve clini-
cal outcomes and decrease the associated resource utili-
zation and costs. So far, there is limited information
regarding these conditions among people with diabetes
in developing countries. We therefore conducted this
study with the objectives to assess the prevalence of
anxiety and depression in a large outpatient sample of
people with type 2 diabetes, and to identify associated
factors amongst study participants. Studies on the asso-
ciation between Metabolic Syndrome (MetS) with anxi-
ety and depression have reported inconsistent and
conflicting findings [18-20]. Therefore, in this study we
also aimed to assess the association of metabolic com-
ponents with anxiety and depression among study
participants.
Methods
This was a multi-center cross-sectional study conducted
in four out-patient clinics in Karachi, the largest city
and economic hub of Pakistan, with a population of
over 16 million. Although this was not a population-
based random sample, to render the results more gener-
alizable and to capture a diverse population in terms of
socio-economic stratum and clinical spectrum, both
public and private sectors clinics were included. The
four different types of clinics represented family
medicine, internal medicine, specific diabetes care and
endocrine clinics.
All persons with type 2 diabetes attending these clinics
for follow-up visit were included. However, persons suf-
fering from type 1 diabetes, gestational diabetes, prior
diagnosis of anxiety and/or depression, patients whose
family member (parent, sibling, spouse, and child) died
in last six weeks, and/or those who lost their job during
the same time period, were excluded. Even though, no
harm was expected to occur to any of the study partici-
pant, the study questionnaire was reviewed and
approved by the Research Committee of the department
of Family Medicine, Aga Khan University, Karachi. Per-
mission was also taken from all the studied clinics. Full
confidentiality of the data collected was ensured to all
the study participants and all interviews were taken after
participant’s consent.
In all, 1000 eligible people with type 2 diabetes from
the four clinics were approached consecutively to parti-
cipate in the study. Final analysis was done on 889 parti-
cipants, the remaining 87 patients having refused to
participate while information was missing for 24
records. All data were collected and edited by medical
graduates specifically trained for this task.
A pre-tested structured questionnaire was used to col-
lect information on socio-demographic and clinical
characteristics. For this study, physical activity was
defined as ‘regular’ if a person was doing at least 20
minutes exercise or brisk walk, four or more times per
week. Respondents who were currently smoking and
smoked at least 100 cigarettes in their lifetime were
defined as ‘current smokers’. Individuals were classified
as hypertensive if they were previously diagnosed and
were currently on anti-hypertensive medication.
Ischemic heart disease (IHD) was considered to exist if
there was a history of angina and/or myocardial infarc-
tion elicited among study subjects and documented in
medical records. Similarly, other variables like height,
weight, blood pressure (BP), fasting blood glucose (BG)
and fasting blood triglycerides (BT) were noted from
patients’ medical record. A validated Urdu (local lan-
guage) version of the Hospital Anxiety and Depression
Scale (HADS) was used to screen anxiety and depression
among study participants. This scale is extensively used
world-wide to assess anxiety and depression among
patients with various diseases, including with diabetes
[21-23].
Data were analyzed using SPSS - version 17. Propor-
tions were calculated for all variables of interest. Missing
values of fasting BG (19.2%) and fasting BT (22.3%)
were imputed by using Linear Interpolation method.
Univariate analysis was done to assess the relationship
between outcome variables (anxiety, depression) and
their associated factors by using chi-square test and
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crude odds ratios (OR) with 95% Confidence Interval
(CI). Multivariable analysis using multiple logistic
regression was carried out to evaluate the combined
effect of several factors associated with anxiety and
depression among persons with type 2 diabetes after
adjusting for confounding variables. Results are repre-
sented as adjusted odds ratios (AOR) with 95% CI,
which express the effect magnitude of each category on
the outcome, relative to the reference category. Compo-
nents of MetS (systolic BP, diastolic BP, fasting BG, fast-
ing BT and BMI) were taken as continuous variables in
assessing the associations with anxiety and depression.
Results
A majority (57.9%) of study participants were found
positive for anxiety (95% CI: 54.7 - 61.2) while nearly
half (43.5%) were positive for depression (95% CI: 40.3 -
46.8). Distribution of study participants by socio-
demographic and clinical information is presented in
Table 1. There was a slight preponderance of females
(57.5%) and of older people (56.4%) in our sample. The
majority was currently married and lived with their
spouse (88%) and had schooling of more than 5 years
(60.4%). Most study participants had diabetes for more
than 5 years (59.5%) and were physically inactive
(65.4%). Nearly half (43.6%) were taking a single hypo-
glycemic drug and/or were practicing lifestyle modifica-
tions. In all, 40.8% and 24.3% of patients had also been
diagnosed with hypertension and IHD respectively.
Results of the univariate and multivariable analyses for
factors associated with anxiety are given in Table 2. In
univariate analysis, factors significantly associated with
anxiety among study participants were: physical inactiv-
ity, having hypertension, and having IHD. Results of
multivariable analysis also showed these factors to be
independently associated with anxiety: physical inactivity
(AOR = 1.47, 95% CI: 1.01 - 1.97), having hypertension
(AOR = 1.52, 95% CI: 1.14 - 2.03) and having IHD
(AOR = 3.83, 95% CI: 2.63 - 5.58).
In Table 3, results of univariate and multivariable ana-
lyses for associations with depression are presented. Fac-
tors found to be significantly associated with depression
were: being female, being of older age, not living with
spouse, having schooling of more than 5 years, disease
duration more than 5 years, being physically inactive,
having hypertension, and having IHD. However, in mul-
tivariable analysis, factors independently associated with
depression were: being female (AOR = 6.91, 95% CI:
4.90 - 9.76), of older age (AOR = 3.35, 95% CI: 2.42 -
4.65), hypertension (AOR = 1.83, 95% CI: 1.34 - 2.50)
and IHD (AOR = 2.45, 95% CI: 1.70 - 3.53).
Simple and adjusted odds ratios (95% CI) for meta-
bolic components associated with anxiety is presented in
Table 4, and depression in Table 5. The metabolic com-
ponents found to be associated with anxiety at univari-
ate analysis included systolic BP, fasting BG, fasting BT
and BMI. However, multivariable analysis revealed systo-
lic BP (AOR = 1.009, 95% CI: 1.002 - 1.017), fasting BG
(AOR = 1.002, 95% CI: 1.000 - 1.003) and fasting BT
(AO R = 1.002, 95% CI: 1.001 - 1.004) to be associated
with anxiety. Metabolic components found to be asso-
ciated with depression at univariate analysis as well as at
multivariate analysis were systolic BP (AOR = 1.017,
95% CI: 1.007 - 1.027), fasting BG (AOR = 1.004, 95%
CI: 1.003 - 1.006), fasting BT (AOR = 1.004, 95% CI:
1.002 - 1.005) and BMI (AOR = 1.030, 95% CI: 1.002 -
1.058).
Discussion
It is well documented that development of co-morbid
anxiety and/or depression in people with diabetes not
only leads to increased disease severity, complications,
work disability, poor quality of life but is also associated
with increased use of medical services and substantially
higher health care costs [3,4,24,25].
Table 1 Distribution of study participants by socio-
demographic and clinical information
Characteristics Number Percent
Sex
Male 378 42.5
Female 511 57.5
Age
Up to 50 years 388 43.6
> 50 years 501 56.4
Marital status
Living with spouse 782 88.0
Not living with spouse 107 12.0
Education
Up to 5 years of schooling 257 55.6
> 5 years of schooling 258 60.4
Duration of disease
Up to 5 years 360 40.5
> 5 years 529 59.5
Taking treatment
Single drug therapy 388 43.6
Combination drug therapy 501 56.4
Physically active
Yes 308 34.6
No 581 65.4
Having Hypertension
No 526 59.2
Yes 363 40.8
Having Ischemic heart disease
No 673 75.7
Yes 216 24.3
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A higher prevalence of anxiety and depression has
been reported among people with chronic diseases
[26,27] including diabetes [7,8]. It is also reported in
general as well as in patient populations, that depression
and other psychological problems are more prevalent in
developing countries [28-30]. There are some possible
explanations are reported about the high levels of anxi-
ety and depression in developing countries compared to
developed countries like higher level of gender inequi-
ties, social insecurity, lower level of education, greater
level of poverty, financial difficulties and other forms of
economic stressors [29,30]. In our study as well, high
proportions of patients with type 2 diabetes were found
positive for anxiety and depression, 58% and 44%
respectively. These estimates are almost twice as high as
found among people with diabetes in developed coun-
tries [7,15,16].
It is well known that being female is significantly asso-
ciated with depression in general populations [29,30]
and also among people with diabetes [15,16] and this
study also showed a similar association. A possible
explanation is that women play many gender specific
roles, which exposes them to increased work demands and
responsibilities. Furthermore, the social role attributed to
women (passivity, dependence and emotional expression),
allows them to be more emotional and extroversive in nat-
ure, in comparison to men [2,30]. Hence being female is
an independent factor associated with depression.
Researchers [24,31] reported a significant association
of age with depression and other psychological disor-
ders. This study also showed increased age as an inde-
pendent factor for depression. It is well reported that
older patients face many challenges including isolation,
more diseases and disabilities; hence making them more
prone to developing psychological conditions [32]. Simi-
larly, duration of diabetes is also associated with devel-
opment of depression in this study and has been
reported by other researchers as well [31,33]. Increased
duration of the disease is known to significantly increase
the risk of developing diabetic complications and health
care expenditures [3], as a result such patients are more
prone to develop psychological illnesses.
Table 2 Univariate and multivariable analysis for factors associated with anxiety among study participants
Characteristics Had anxiety
n (%)
p-value OR
(95% CI)
p-value AOR
(95% CI)
Sex 0.168
Male 229 (60.6) 1.0 – –
Female 286 (56.0) 0.83 (0.63-1.08)
Age 0.230
Up to 50 years 216 (55.7) 1.0 – –
> 50 years 299 (59.7) 1.18 (0.90-1.54)
Marital status 0.405
Living with spouse 457 (58.4) 1.0 – –
Not living with spouse 58 (54.2) 0.84 (0.56-1.26)
Education 0.148
Up to 5 years of schooling 258 (60.4) 1.0 – –
> 5 years of schooling 257 (55.6) 0.82 (0.63-1.07)
Duration of disease 0.365
Less than 5 years 202 (56.1) 1.0 – - -
More than 5 years 313 (59.2) 1.13 (0.86-1.49)
Taking treatment 0.354
Single drug therapy 218 (56.2) 1.0 – - -
Multiple drug therapy 297 (59.3) 1.14 (0.87-1.49)
Physically active 0.001 0.009
Yes 156 (50.6) 1.0 1.0
No 359 (61.8) 1.58 (1.19-2.08) 1.47 (1.01-1.97)
Having Hypertension < 0.001 0.004
No 277 (52.7) 1.0 1.0
Yes 238 (65.6) 1.71 (1.29-2.26) 1.52 (1.14-2.03)
Having IHD < 0.001 < 0.001
No 340 (50.5) 1.0 1.0
Yes 175 (81.0) 4.18 (2.88-6.07) 3.83 (2.63-5.58)
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Due to an increased release of b-endorphins and brain
neurotransmitters during exercise, physical activity is
known to have protective physiological effects on
depression and serves as a buffer against development of
psychological illness [34,35]. Khuwaja et al [2] and Hong
et al [36] identified that physical activity was inversely
associated with the presence of anxiety depression
among various groups of population. In our study also
physical inactivity was found to be independently asso-
ciated with anxiety.
Cardiovascular diseases have been identified as an
independent factor for anxiety and depression in various
studies among people with diabetes [4,17,27]. Similarly,
a positive contribution of type 2 diabetes to increased
rates of depression and/or anxiety disorders in patients
with hypertension has been suggested [37]. In this study,
Table 3 Univariate and multivariable analysis for factors associated with depression among study participants
Characteristic Had depression
n (%)
p-value OR
(95% CI)
p-value AOR
(95% CI)
Sex < 0.001 < 0.001
Male 85 (22.5) 1.0 1.0
Female 302 (59.1) 4.98 (3.69-6.72) 6.91 (4.90-9.76)
Age < 0.001 < 0.001
Up to 50 years 125 (32.2) 1.0 1.0
> 50 years 262 (52.3) 2.71 (1.75-3.04) 3.35 (2.42-4.65)
Marital status 0.001
Living with spouse 325 (41.6) 1.0 – –
Not living with spouse 62 (57.9) 1.94 (1.29-2.92)
Education < 0.001
Up to 5 years of schooling 161 (34.8) 1.0 – –
> 5 years of schooling 226 (52.9) 2.10 (1.61-2.75)
Duration of disease 0.030
Less than 5 years 141 (39.2) 1.0 – –
More than 5 years 246 (46.5) 1.35 (1.03-1.77)
Taking treatment 0.406
Single drug therapy 175 (45.1) 1.0 – –
Multiple drug therapy 212 (42.3) 0.89 (0.68-1.17)
Physically active < 0.001
Yes 108 (35.1) 1.0 – –
No 279 (48.0) 1.71 (1.29-2.28)
Having Hypertension < 0.001 < 0.001
No 185 (35.2) 1.0 1.0
Yes 202 (55.6) 2.31 (1.76-3.04) 1.83 (1.34-2.50)
Having IHD < 0.001 < 0.001
No 261 (38.8) 1.0 1.0
Yes 126 (58.3) 2.21 (1.62-3.02) 2.45 (1.70-3.53)
Table 4 Univariate and multivariable analysis for metabolic factors associated with anxiety among study participants
Characteristics Crude b
(SE)
p -value OR
(95% CI)
Adjusted b
(SE)
p-value AOR
(95% CI)
Systolic BP* 0.009 (0.004) 0.015 1.009 (1.002-1.017) 0.009 (0.004) 0.013 1.009 (1.002-1.017)
Diastolic BP* 0.003 (0.006) 0.570 1.003 (0.992-1.015) – – –
Fasting BG** 0.002 (0.001) 0.048 1.002 (1.000-1.003) 0.002 (0.001) 0.080 1.002 (1.000-1.003)
Fasting BT*** 0.003 (0.001) 0.002 1.003 (1.001-1.004) 0.002 (0.001) 0.003 1.002 (1.001-1.004)
BMI**** 0.017 (0.013) 0.195 1.017 (0.991-1.045) – – –
*BP: Blood Pressure
**BG: Blood Glucose
***BT: Blood Triglycerides
****BMI: Body Mass Index
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having IHD and hypertension were also found to be
independently associated with both anxiety and depres-
sion. These results reflect the fact that the likelihood of
anxiety and depression increases with development of
complications among people with diabetes.
There are inconsistent and conflicting findings regard-
ing the relationship of MetS with anxiety and depression
[38]. Some studies observe that MetS is associated with
depression [18,19] while others have found no associa-
tion with either entity [20]. Underlying issues in all such
studies are that syndrome definitions were not standar-
dized, and their use could either mask or reflect associa-
tions with their specific components. However, a core
component of all such definitions is obesity and, among
people with diabetes, obesity has been consistently iden-
tified as an independent factor associated with depres-
sion [18,20,39]. In our study also, BMI was found to be
independently associated with depression, while associa-
tions of other MetS components (elevated systolic BP,
fasting BG, fasting TG) were observed with both anxiety
and depression. Our results therefore support the asso-
ciation of obesity and other MetS components with
these conditions.
This study has some limitations to be noted. Being a
cross-sectional study, we could not assess the temporal
relationships between anxiety, depression and other dia-
betes related variables. Causality therefore cannot be
attributed. Some missing values of fasting BG and fast-
ing BT were imputed. Values of High Density Lipopro-
teins (another component of MetS) were largely
missing; hence not analyzed. All the study participants
were only from clinics of urban setting, so caution must
be exercised in generalizing these results.
Conclusion
Results of this multi-centre study, from one of the lar-
gest metropolitan cities of the developing world, high-
light alarming findings which justify immediate
recognition and action, both at clinical and public health
levels; as both diabetes and anxiety/depression are major
health issues to be prevented and treated. We suggest
that all patients with diabetes should be assessed for
these conditions so that they also can be managed so as
to improve clinical outcomes. Health care providers
engaged in diabetes care and treatment should be
trained and updated regarding case-finding and manage-
ment of these psychological conditions. Further research
is needed to clarify the underlying mechanisms of asso-
ciated factors and also to test interventions to reduce
the risk of co-morbid anxiety and depression and their
adverse outcomes.
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